Cadrenal Therapeutics Inc (CVKD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2017 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -10,651 | -8,357 | -6,714 | N/A |
| Depreciation Amortization | 2 | 16 | 68 | N/A |
| Accounts payable and accrued liabilities | 1,335 | -238 | 405 | N/A |
| Other Working Capital | 1,873 | 144 | 608 | N/A |
| Other Operating Activity | 84 | 4,905 | 4,429 | 0 |
| Operating Cash Flow | $-7,358 | $-3,530 | $-1,205 | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -7 | -3 | -2 | N/A |
| Investing Cash Flow | $-7 | $-3 | $-2 | $N/A |
| Cash Flows From Financing Activities | ||||
| Change In Short Term Borrowing | N/A | N/A | 220 | N/A |
| Debt Issued | N/A | N/A | 1,012 | N/A |
| Common Stock Issued | 4,806 | 12,154 | 8 | N/A |
| Other Financing Activity | 4,173 | -250 | 0 | 0 |
| Financing Cash Flow | $8,980 | $11,904 | $1,240 | $N/A |
| Beginning Cash Position | 8,403 | 33 | N/A | N/A |
| End Cash Position | 10,018 | 8,403 | 33 | N/A |
| Net Cash Flow | $1,615 | $8,370 | $33 | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -7,358 | -3,530 | -1,205 | N/A |
| Capital Expenditure | -7 | -3 | -2 | N/A |
| Free Cash Flow | -7,364 | -3,534 | -1,207 | 0 |